These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15566879)

  • 1. Isolation of an in vitro transmissible agent with reverse transcriptase activity from a blood donor with a borderline-positive HIV-1 serology for more than five years.
    Schüpbach J; Pyra H; Jendis J; Tomasik Z; Böni J
    Clin Diagn Virol; 1996 May; 5(2-3):197-203. PubMed ID: 15566879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitive detection and quantification of particle-associated reverse transcriptase in plasma of HIV-1-infected individuals by the product-enhanced reverse transcriptase (PERT) assay.
    Böni J; Pyra H; Schüpbach J
    J Med Virol; 1996 May; 49(1):23-8. PubMed ID: 8732867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasensitive retrovirus detection by a reverse transcriptase assay based on product enhancement.
    Pyra H; Böni J; Schüpbach J
    Proc Natl Acad Sci U S A; 1994 Feb; 91(4):1544-8. PubMed ID: 7509077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of HIV type 1 western blot-indeterminate blood donors for the presence of human or bovine retroviruses.
    Sherman MP; Dock NL; Ehrlich GD; Sninsky JJ; Brothers C; Gillsdorf J; Bryz-Gornia V; Poiesz BJ
    AIDS Res Hum Retroviruses; 1995 Mar; 11(3):409-14. PubMed ID: 7786586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly sensitive qualitative and quantitative detection of reverse transcriptase activity: optimization, validation, and comparative analysis with other detection systems.
    Yamamoto S; Folks TM; Heneine W
    J Virol Methods; 1996 Sep; 61(1-2):135-43. PubMed ID: 8882946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of hepatitis C virus in Brazilian blood donors using a reverse transcriptase nested polymerase chain reaction: comparison with enzyme immunoassay and recombinant protein immunoblot assay.
    Gonçales NS; Costa FF; Vassallo J; Gonçales FL
    Rev Inst Med Trop Sao Paulo; 2000; 42(5):263-7. PubMed ID: 11058936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological and nucleic acid analyses for HIV and HTLV infection on archival human plasma samples from Zaire.
    Dube DK; Dube S; Erensoy S; Jones B; Bryz-Gornia V; Spicer T; Love J; Saksena N; Lechat MF; Shrager DI
    Virology; 1994 Jul; 202(1):379-89. PubMed ID: 7912021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detectionof reverse transcriptase activity in live attenuated virus vaccines.
    Böni J; Stalder J; Reigel F; Schüpbach J
    Clin Diagn Virol; 1996 Feb; 5(1):43-53. PubMed ID: 15566860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic challenges: lymphotropic sero-"questionables".
    Fox E; Constantine NT; Rodier G; Abbatte EA
    East Afr Med J; 1992 Oct; 69(10):563-5. PubMed ID: 1473510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of different RT enzyme standards for quantitation of retroviruses using the single-tube fluorescent product-enhanced reverse transcriptase assay.
    Ma YK; Khan AS
    J Virol Methods; 2009 May; 157(2):133-40. PubMed ID: 19186191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low prevalence of HCV, HIV, and HTLV-I/II infection markers in northwestern Greece: results of a 3-year prospective donor study (1995-1997).
    Zervou EK; Boumba DS; Liaskos C; Georgiadou S; Tsianos EV; Dalekos GN
    Eur J Intern Med; 2003 Feb; 14(1):39-44. PubMed ID: 12554009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The first decade of human retroviruses: a nomenclature for the clinician.
    Lucey DR
    Mil Med; 1991 Oct; 156(10):555-7. PubMed ID: 1660967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity of two enzyme-linked immunosorbent assay tests in relation to western blot in detecting human T-cell lymphotropic virus types I and II infection among HIV-1 infected patients from São Paulo, Brazil.
    Caterino-de-Araujo A; de los Santos-Fortuna E; Meleiro MC; Suleiman J; Calabrò ML; Favero A; De Rossi A; Chieco-Bianchi L
    Diagn Microbiol Infect Dis; 1998 Mar; 30(3):173-82. PubMed ID: 9572023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The reverse transcriptase activity in cell-free medium of chicken embryo fibroblast cultures is not associated with a replication-competent retrovirus.
    Khan AS; Maudru T; Thompson A; Muller J; Sears JF; Peden KW
    J Clin Virol; 1998 Jul; 11(1):7-18. PubMed ID: 9784139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Product-enhanced reverse transcriptase assay for replication-competent retrovirus and lentivirus detection.
    Sastry L; Xu Y; Duffy L; Koop S; Jasti A; Roehl H; Jolly D; Cornetta K
    Hum Gene Ther; 2005 Oct; 16(10):1227-36. PubMed ID: 16218784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory characterization of human T cell lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) infections in blood donors from Sao Paulo, Brazil.
    Segurado AA; Malaque CM; Sumita LM; Pannuti CS; Lal RB
    Am J Trop Med Hyg; 1997 Aug; 57(2):142-8. PubMed ID: 9288805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview: diagnostic tests for viral infections transmitted by blood.
    Holland PV
    Nucl Med Biol; 1994 Apr; 21(3):407-17. PubMed ID: 9234305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human retroviruses in leukaemia and AIDS: reflections on their discovery, biology and epidemiology.
    Karpas A
    Biol Rev Camb Philos Soc; 2004 Nov; 79(4):911-33. PubMed ID: 15682876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A modified single-tube one-step product-enhanced reverse transcriptase (mSTOS-PERT) assay with heparin as DNA polymerase inhibitor for specific detection of RTase activity.
    Fan XY; Lü GZ; Wu LN; Chen JH; Xu WQ; Zhao CN; Guo SQ
    J Clin Virol; 2006 Dec; 37(4):305-12. PubMed ID: 16971176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HTLV-1 in Switzerland: low prevalence of specific antibodies in HIV risk groups, high prevalence of cross-reactive antibodies in normal blood donors.
    Schüpbach J; Baumgartner A; Tomasik Z
    Int J Cancer; 1988 Dec; 42(6):857-62. PubMed ID: 3192331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.